X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (28) 28
mice (19) 19
biochemistry & molecular biology (16) 16
humans (16) 16
index medicus (14) 14
oncology (13) 13
female (10) 10
3t3 cells (9) 9
male (9) 9
expression (8) 8
kinetics (8) 8
phosphorylation (8) 8
rats (8) 8
signal transduction - drug effects (8) 8
cancer (7) 7
insulin (7) 7
signal transduction (7) 7
cell line, tumor (6) 6
gene amplification (6) 6
growth hormone - pharmacology (6) 6
mutations (6) 6
piperazines - pharmacology (6) 6
pyrazoles - pharmacology (6) 6
benzamides - pharmacology (5) 5
chemotherapy (5) 5
gtp-binding proteins - metabolism (5) 5
lung cancer (5) 5
middle aged (5) 5
adipose tissue - metabolism (4) 4
aged (4) 4
antineoplastic agents - pharmacology (4) 4
biomarkers (4) 4
biophysics (4) 4
calcium-calmodulin-dependent protein kinases - metabolism (4) 4
cell differentiation - drug effects (4) 4
clinical trials (4) 4
enzyme activation (4) 4
enzyme inhibitors - pharmacology (4) 4
insulin - pharmacology (4) 4
isoproterenol - pharmacology (4) 4
map kinase (4) 4
patients (4) 4
protein-tyrosine kinases - metabolism (4) 4
receptors, fibroblast growth factor - antagonists & inhibitors (4) 4
substrate specificity (4) 4
tumors (4) 4
tyrosine phosphorylation (4) 4
activation (3) 3
adenylyl cyclases - metabolism (3) 3
adipocytes - cytology (3) 3
adipose conversion (3) 3
adult (3) 3
amplification (3) 3
analysis (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
article (3) 3
breast-cancer (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
cell biology (3) 3
cell differentiation - physiology (3) 3
cell membrane - metabolism (3) 3
cell proliferation - drug effects (3) 3
chemistry, medicinal (3) 3
colforsin - pharmacology (3) 3
cyclic amp - pharmacology (3) 3
cyclic-amp (3) 3
differentiation (3) 3
factor-i (3) 3
gene expression profiling (3) 3
growth hormone - physiology (3) 3
hypertension (3) 3
inhibitor (3) 3
lung cancer, non-small cell (3) 3
lung neoplasms - genetics (3) 3
medical prognosis (3) 3
medical research (3) 3
mice, nude (3) 3
models, molecular (3) 3
molecular targeted therapy (3) 3
mutation (3) 3
neoplasm metastasis (3) 3
non-small cell lung carcinoma (3) 3
oligonucleotides, antisense - pharmacology (3) 3
pertussis toxin (3) 3
receptor, fibroblast growth factor, type 1 - genetics (3) 3
receptor, insulin - metabolism (3) 3
sensitivity (3) 3
treatment outcome (3) 3
tyrosine - metabolism (3) 3
xenograft model antitumor assays (3) 3
1-methyl-3-isobutylxanthine - pharmacology (2) 2
11-beta-hydroxysteroid dehydrogenase type 1 - antagonists & inhibitors (2) 2
11-beta-hydroxysteroid dehydrogenase type 1 - metabolism (2) 2
3t3-f442a cell (2) 2
3t3-l1 cells (2) 2
adenylate-cyclase (2) 2
adipocytes (2) 2
adipocytes - drug effects (2) 2
adipocytes - enzymology (2) 2
adipose tissue - drug effects (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 05/2017, Volume 317, Issue 18, pp. 1844 - 1853
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2019, Volume 120, Issue 2, pp. 141 - 153
Cancers of Unknown Primary (CUP) comprise a heterogeneous clinical entity of confirmed metastatic cancer where the primary site of origin is undetectable. It... 
LUNG-CANCER | CIRCULATING TUMOR-CELLS | EARLY DISSEMINATION | PAN-CANCER | ONCOLOGY | PRIMARY SITE | TREATMENT OUTCOMES | COLORECTAL-CANCER | GENE-EXPRESSION | FREE DNA | PRIMARY ORIGIN | Carcinogens | Historical account | Biopsy | Medical prognosis | Biological evolution | Biomarkers | Biology | Patients | Carcinogenesis | Tumors | Cancer | Metastases | Index Medicus | Tumour biomarkers | Review | Cancer of unknown primary | Cancer genomics
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66963
Phase III trials of the anti-insulin-like growth factor-1 receptor (IGF1R) antibody figitumumab in non-small cell lung cancer (NSCLC) patients have been... 
IGF-I | HUMAN-BREAST-CANCER | PLASMA-LEVELS | CLINICAL DEVELOPMENT | HYBRID RECEPTORS | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | BINDING PROTEIN-3 | MONOCLONAL-ANTIBODIES | EXPRESSION | LINES | Cell Survival - drug effects | Receptor, IGF Type 1 - metabolism | Receptor, IGF Type 1 - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Pyrimidines - pharmacology | Molecular Targeted Therapy | Receptor, Insulin - antagonists & inhibitors | Isoxazoles - pharmacology | Signal Transduction - drug effects | Cell Line, Tumor | Receptor, Insulin - metabolism | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Viral antibodies | Tyrosine | Prevention | Analysis | Antibodies | Lung cancer, Small cell | Lung cancer, Non-small cell | Phosphotransferases | Cancer | Cell proliferation | Phosphorylation | Insulin-like growth factor I | Lung cancer | Clinical trials | Homology | AKT protein | Biochemistry | Insulin-like growth factors | Kinases | Signal transduction | Rodents | Inhibition | Insulin-like growth factor II | Protein-tyrosine kinase | Immunoglobulins | Medical treatment | Non-small cell lung carcinoma | Metabolism | Insulin | Studies | Signaling | Chemotherapy | Inhibitors | Cell lines | Ligands | Prostate
Journal Article
Cancer Discovery, ISSN 2159-8274, 08/2016, Volume 6, Issue 8, pp. 838 - 851
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2013, Volume 19, Issue 9, pp. 2572 - 2583
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0149628
FGFR1 amplification occurs in similar to 20% of sqNSCLC and trials with FGFR inhibitors have selected FGFR1 amplified patients by FISH. Lung cancer cell lines... 
CELL LUNG-CANCER | SURVIVAL | MESSENGER-RNA | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | HUMAN BREAST-CANCER | EXPRESSION | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Reproducibility of Results | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Gene Expression Regulation, Neoplastic | In Situ Hybridization, Fluorescence | Cell Line, Tumor - drug effects | Chromosomes, Human, Pair 8 | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Piperazines - pharmacology | Gene Amplification | Comparative Genomic Hybridization | Benzamides - pharmacology | Cell Proliferation - drug effects | Carcinoma, Non-Small-Cell Lung - drug therapy | Molecular Targeted Therapy - methods | Pyrazoles - pharmacology | Physiological aspects | Development and progression | Genetic aspects | Research | Lung cancer, Non-small cell | Fibroblast growth factor receptors | Copy number | Genes | Lung cancer | Clinical trials | Oncology | Statistical methods | Kinases | Cell growth | Animal tissues | Fibroblast growth factor receptor 1 | Medical research | Statistical analysis | Non-small cell lung carcinoma | Breast cancer | Tumor cell lines | Gene expression | Ribonucleic acid--RNA | Amplification | Sensitivity | Gene amplification | Inhibitors | Chromosome 8 | Biomarkers | Protein expression | Mutation | Tumors | RNA | Ribonucleic acid
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS4577 - TPS4577
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 10/2015, Volume 8, Issue 1, p. 119
Background: Urothelial cancers (UC) are the fourth most common tumours worldwide after prostate (or breast), lung and colorectal cancer. Despite recent... 
AZD4547 | Urothelial cancer | Biomarker | FGFR | BLADDER-CANCER | GUIDELINES | AMPLIFICATION | ONCOLOGY | PREDICT | SENSITIVE FGFR2 | PROTEIN EXPRESSION | MUTATIONS | HEMATOLOGY | CARCINOMA | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Pyrazoles - therapeutic use | Humans | Middle Aged | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Kidney Pelvis - metabolism | Male | Antineoplastic Agents - therapeutic use | Ureteral Neoplasms - metabolism | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Ureteral Neoplasms - drug therapy | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | Benzamides - therapeutic use | Urinary Bladder Neoplasms - genetics | Gene Expression Regulation, Neoplastic - drug effects | Urinary Bladder Neoplasms - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Ureteral Neoplasms - genetics | Kidney Pelvis - pathology | In Situ Hybridization, Fluorescence | Piperazines - therapeutic use | Signal Transduction - genetics | Urinary Bladder Neoplasms - drug therapy | Signal Transduction - drug effects | Medical research | Care and treatment | Chemotherapy | Analysis | Colorectal cancer | Medicine, Experimental | Development and progression | Fibroblast growth factors | Metastasis | Cancer
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 5095 - 5095
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2012, Volume 18, Issue 24, pp. 6658 - 6667
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 9/2017, Volume 23, Issue 18, pp. 5366 - 5373
Journal Article